JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$4.76B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.21B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$3.81B |
| 4 |
Apple
AAPL
|
+$3.39B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$3.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.48B |
| 2 |
S&P Global
SPGI
|
+$2.45B |
| 3 |
Coca-Cola
KO
|
+$1.73B |
| 4 |
Adobe
ADBE
|
+$1.59B |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.3B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.97% |
| 2 | Technology | 21.69% |
| 3 | Healthcare | 9.58% |
| 4 | Consumer Discretionary | 9.07% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
LGTY
4401
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $691K | ﹤0.01% |
60,367
+16,454
| +37% | +$185K |
2017 Q4
25 quarters
|
|
4402
Invesco Global Water ETF
PIO
$266M
| $691K | ﹤0.01% |
16,029
-200
| -1% | -$8.01K |
2023 Q2
3 quarters
|
|
4403
Clover Health Investments
CLOV
$2.5B
| $690K | ﹤0.01% |
868,542
+741,421
| +583% | +$675K |
2021 Q2
11 quarters
|
|
4404
LendingTree
TREE
$340M
| $689K | ﹤0.01% |
16,279
-15,605
| -49% | -$546K |
2017 Q1
28 quarters
|
|
4405
Kamada
KMDA
$457M
| $687K | ﹤0.01% |
122,380
+108,707
| +795% | +$643K |
2023 Q4
1 quarter
|
|
4406
Peoples Financial Services
PFIS
$687M
| $686K | ﹤0.01% |
15,919
+4,458
| +39% | +$191K |
2017 Q4
25 quarters
|
|
4407
Adaptive Biotechnologies
ADPT
$4.21B
| $685K | ﹤0.01% |
213,507
-68,461
| -24% | -$265K |
2019 Q2
19 quarters
|
|
|
NXDR
4408
Nextdoor Holdings
NXDR
$952M
| $683K | ﹤0.01% |
303,635
+187,609
| +162% | +$351K |
2022 Q2
7 quarters
|
|
4409
Vermilion Energy
VET
$1.76B
| $682K | ﹤0.01% |
54,814
+22,243
| +68% | +$249K |
2013 Q2
43 quarters
|
|
4410
GCM Grosvenor
GCMG
$790M
| $681K | ﹤0.01% |
70,500
+24,954
| +55% | +$217K |
2021 Q2
11 quarters
|
|
4411
iShares iBonds Dec 2032 Term Corporate ETF
IBDX
$1.74B
| $681K | ﹤0.01% |
+27,431
| New | +$680K |
2024 Q1
0 quarters
|
|
|
LYRA
4412
DELISTED
LYRA THERAPEUTICS INC
LYRA
| $680K | ﹤0.01% |
2,188
+1,525
| +230% | +$406K |
2020 Q2
15 quarters
|
|
4413
Lindblad Expeditions
LIND
$2.28B
| $680K | ﹤0.01% |
72,929
+48,852
| +203% | +$450K |
2017 Q4
25 quarters
|
|
4414
Gilat Satellite Networks
GILT
$705M
| $679K | ﹤0.01% |
125,094
+21,148
| +20% | +$127K |
2019 Q3
18 quarters
|
|
4415
CALL
Nice
NICE
$6.84B
| $678K | ﹤0.01% |
2,600
-10,000
| -79% | -$2.27M |
2023 Q4
1 quarter
|
|
4416
JPMorgan Diversified Return US Mid Cap Equity ETF
JPME
$469M
| $678K | ﹤0.01% |
6,834
+158
| +2% | +$14.7K |
2022 Q4
5 quarters
|
|
4417
Arrow Financial
AROW
$680M
| $676K | ﹤0.01% |
27,021
+10,033
| +59% | +$251K |
2016 Q4
29 quarters
|
|
4418
United States Brent Oil Fund
BNO
$768M
| $676K | ﹤0.01% |
21,172
+760
| +4% | +$22.4K |
2018 Q4
21 quarters
|
|
4419
Orthofix Medical
OFIX
$380M
| $674K | ﹤0.01% |
46,397
+9,761
| +27% | +$135K |
2015 Q2
35 quarters
|
|
4420
Scholar Rock
SRRK
$5.29B
| $673K | ﹤0.01% |
37,914
-12,601
| -25% | -$198K |
2018 Q3
22 quarters
|
|
|
RPC
4421
Ridgepost Capital
RPC
$881M
| $671K | ﹤0.01% |
79,655
-5,186
| -6% | -$45.4K |
2023 Q2
3 quarters
|
|
4422
Stagwell
STGW
$2.09B
| $671K | ﹤0.01% |
107,809
+54,017
| +100% | +$338K |
2021 Q2
11 quarters
|
|
4423
Greenlight Captial
GLRE
$486M
| $668K | ﹤0.01% |
53,583
+7,013
| +15% | +$82K |
2017 Q4
25 quarters
|
|
|
XXCH
4424
DELISTED
Direxion Daily MSCI Emerging Markets ex China Bull 2X Shares
XXCH
| $667K | ﹤0.01% |
+25,000
| New | +$649K |
2024 Q1
0 quarters
|
|
4425
Omega Flex
OFLX
$266M
| $667K | ﹤0.01% |
9,400
+1,281
| +16% | +$90.9K |
2017 Q4
25 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2024 Portfolio in Review
As of Q1 2024, JP Morgan Chase held 8,132 positions worth $1.18T, up 14% from $1.04T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
JP Morgan Chase deployed $48.7B of net new capital in Q1 2024, opening 625 new positions and adding to 3,255 existing holdings. Its largest new stake was Flutter Entertainment: 1,314,201 shares worth $260M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vanguard Total International Bond ETF, an estimated $2.48B trimmed.
- JP Morgan Chase's largest Q1 2024 buy was Flutter Entertainment: 1,314,201 shares worth $260M.
- JP Morgan Chase added most to Vanguard S&P 500 ETF in Q1 2024, an estimated $4.76B increase.
- JP Morgan Chase's biggest Q1 2024 reduction was Vanguard Total International Bond ETF, cutting an estimated $2.48B.
- JP Morgan Chase fully exited BlackRock Flexible Income ETF in Q1 2024, selling an estimated $139M.
- JP Morgan Chase's ten largest holdings make up 21% of its $1.18T portfolio in Q1 2024.
- JP Morgan Chase opened 625 new positions and closed 764 in Q1 2024.
- JP Morgan Chase's portfolio value rose 14% quarter-over-quarter to $1.18T.
Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.